Author information:
(1)Department of Psychiatry, Program in Neuroscience, Rock Hall, University of 
California at San Francisco, San Francisco, CA 94158-2324, USA.
(2)Division of Bioinformatics, Department of Biology, Friedrich-Alexander 
Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
(3)Department of Functional Genomics, MS 84-171, Lawrence Berkeley National 
Laboratory, Berkeley, CA 94720, USA; U.S. Department of Energy Joint Genome 
Institute, Walnut Creek, CA 94598, USA; Center for Neuroscience, University of 
California Davis, Davis, CA 95618, USA.
(4)Department of Psychiatry, Program in Neuroscience, Rock Hall, University of 
California at San Francisco, San Francisco, CA 94158-2324, USA; PLOS, 1160 
Battery Street, San Francisco, CA 94111, USA.
(5)Department of Anatomy, Faculty of Medicine, University Murcia E-30100 and 
IMIB (Instituto Murciano de Investigación Biosanitaria), 30100 Murcia, Spain.
(6)Magee-Womens Research Institute, 204 Craft Avenue, Pittsburgh, PA 15213, USA.
(7)Department of Psychiatry, Program in Neuroscience, Rock Hall, University of 
California at San Francisco, San Francisco, CA 94158-2324, USA; Acetylon 
Pharmaceuticals Inc., Boston, MA 02210, USA.
(8)Allen Institute for Brain Science, Seattle, WA 98103, USA.
(9)Department of Functional Genomics, MS 84-171, Lawrence Berkeley National 
Laboratory, Berkeley, CA 94720, USA; U.S. Department of Energy Joint Genome 
Institute, Walnut Creek, CA 94598, USA; School of Natural Sciences, University 
of California, Merced, CA 95343, USA.
(10)Department of Psychiatry, Program in Neuroscience, Rock Hall, University of 
California at San Francisco, San Francisco, CA 94158-2324, USA. Electronic 
address: john.rubenstein@ucsf.edu.